2,231 2,817 126.28 Profit before Expense 336,244 108,327 227,917 210.40 Sale Expense (83,396) (11,762) 71,634 (609.00) Administrative Expense (131,143) (57,706) 73,437 (127.26) Directors and Executives

costs 13.36 14.48 (1.12) -7.7% Income tax expense 1.45 2.06 (0.61) -29.6% Profit for the quarter (6.96) 9.32 (16.28) -174.6% (1.8%) 2.1% Consolidated financial information (Unit : Million Baht) For three

gain / (loss) from FX – Non-recurring income / (expense) KEY FINANCIAL HIGHLIGHT Sales and Service Income • Sales and service income increased 13.5% year- on-year from Baht 27,747 million in 2016 to Baht

interest income amounting to 2.99 Million Baht. 5. Selling expense decreased amounting to 17.43 Million Baht, accounting for 76.48% from previous year as the Company record transportation expense to customer

fixed interest rate from 2.05 to 3.01 percent per annum to reduce financial cost and risk management from floating interest rate. As a result, the Company has saved interest expense approximately by Baht

2,451 44 1.8 Selling and administrative expenses 305 312 (7) -2.2 Total expenses 2,800 2,763 37 1.3 Profit from operating activities 1,089 1,362 (273) -20.0 Finance cost 379 305 74 24.3 Interest expense

. In order to maintain overall financial results, the Company has initiated strategies focused on improvements in operational efficiency and expense control, such as adapting to the ‘new normal’ of

) -34.6 Cost of service 2,591 2,393 198 8.3 Selling and administrative expenses 303 276 27 9.8 Finance cost 328 312 16 5.1 Interest expense from the MRT Purple Line Project 94 108 (14) -13.0 Total expenses

for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and

expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s